Seelos Therapeutics, Inc.

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

30,550

Value ($000)

Weight

0.0%

2021 Q2 - 2023 Q2 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	37	0.0%	30,550	6/30/2023
2023 Q1	5/15/2023	21	0.0%	30,550	3/31/2023
2022 Q4	2/13/2023	43	0.0%	62,648	12/31/2022
2022 Q3	11/14/2022	65	0.0%	62,648	9/30/2022
2022 Q2	8/11/2022	43	0.0%	62,648	6/30/2022
2022 Q1	5/13/2022	45	0.0%	53,327	3/31/2022
2021 Q4	2/16/2022	97	0.0%	59,663	12/31/2021
2021 Q3	11/4/2021	136	0.0%	56,503	9/30/2021
2021 Q2	8/11/2021	746	0.0%	282,683	6/30/2021